1. Home
  2. ANNX vs CWBC Comparison

ANNX vs CWBC Comparison

Compare ANNX & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.17

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Logo Community West Bancshares

CWBC

Community West Bancshares

N/A

Current Price

$25.91

Market Cap

729.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
CWBC
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
873.3M
729.1M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
ANNX
CWBC
Price
$5.17
$25.91
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$16.50
$28.63
AVG Volume (30 Days)
2.5M
237.0K
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
2.03%
EPS Growth
N/A
344.44
EPS
N/A
0.61
Revenue
N/A
N/A
Revenue This Year
N/A
$39.58
Revenue Next Year
$16,320.74
$17.64
P/E Ratio
N/A
$42.31
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$19.79
52 Week High
$7.18
$28.17

Technical Indicators

Market Signals
Indicator
ANNX
CWBC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ANNX
CWBC

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.

Share on Social Networks: